Theriva Biologics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $15.8M | $30.8M | $20.8M |
| FY2016 | $20.2M | $22.5M | $19.1M |
| FY2017 | $10.2M | $18.8M | $17.1M |
| FY2018 | $3.7M | $30.1M | $28.9M |
| FY2019 | $5.7M | $17.2M | $26.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $15.8M | $30.8M | $20.8M |
| FY2016 | $20.2M | $22.5M | $19.1M |
| FY2017 | $10.2M | $18.8M | $17.1M |
| FY2018 | $3.7M | $30.1M | $28.9M |
| FY2019 | $5.7M | $17.2M | $26.0M |